Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_assertion type Assertion NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_head.
- NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_assertion description "[Vascular complications, hypertension, methylenetetrahydrofolate reductase genotype (RFLP with Hinf I digestion), and total plasma homocysteine (HPLC) were investigated in 389 well-characterized Type I (insulin-dependent) diabetic patients with normal (GFR> or=75 ml x min(-1) x (1.73 m(2))(-1); n=273), or impaired renal function (GFR <75 ml x min(-1) x (1.73 m(2))(-1); n=116).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_provenance.
- NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_assertion evidence source_evidence_literature NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_provenance.
- NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_assertion SIO_000772 12242465 NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_provenance.
- NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_assertion wasDerivedFrom befree-20150227 NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_provenance.
- NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_assertion wasGeneratedBy ECO_0000203 NP1007300.RAhfR9NYtM0vOxw6i2juCd69RMDy9LYz-XchkM6pw1iM0130_provenance.